December 25, 2009, Newsletter Issue #52: What prompted the recall of Bextra?
Tip of the Week
Bextra warning statements regarding cardiovascular safety follow the recent Vioxx recall that occurred on September 30, 2004. The recall was prompted by research findings indicating that patients taking Vioxx for eighteen months double their risk of suffering from a serious heart attack or stroke. Because Bextra, like Vioxx, is a COX-2 selective nonsteroidal anti-inflammatory drugs and because it is so similar to Bextra in its actions on the body, warnings were raised regarding the safety of Bextra and all other COX-2 selective NSAIDs.
About LifeTips
Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.
